162 related articles for article (PubMed ID: 16537196)
1. Use of simulated intestinal fluids with Caco-2 cells and rat ileum.
Patel N; Forbes B; Eskola S; Murray J
Drug Dev Ind Pharm; 2006 Feb; 32(2):151-61. PubMed ID: 16537196
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of fasted and fed state simulated and human intestinal fluids as solvent system in the Ussing chambers model to explore food effects on intestinal permeability.
Wuyts B; Riethorst D; Brouwers J; Tack J; Annaert P; Augustijns P
Int J Pharm; 2015 Jan; 478(2):736-44. PubMed ID: 25510602
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical properties and in vitro intestinal permeability properties and intestinal cell toxicity of silica particles, performed in simulated gastrointestinal fluids.
Sakai-Kato K; Hidaka M; Un K; Kawanishi T; Okuda H
Biochim Biophys Acta; 2014 Mar; 1840(3):1171-80. PubMed ID: 24361607
[TBL] [Abstract][Full Text] [Related]
4. Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and the fed state and their usefulness.
Markopoulos C; Thoenen F; Preisig D; Symillides M; Vertzoni M; Parrott N; Reppas C; Imanidis G
Eur J Pharm Biopharm; 2014 Apr; 86(3):438-48. PubMed ID: 24184673
[TBL] [Abstract][Full Text] [Related]
5. Human intestinal fluid factors affecting intestinal drug permeation in vitro.
Riethorst D; Brouwers J; Motmans J; Augustijns P
Eur J Pharm Sci; 2018 Aug; 121():338-346. PubMed ID: 29902511
[TBL] [Abstract][Full Text] [Related]
6. Biorelevant media resistant co-culture model mimicking permeability of human intestine.
Antoine D; Pellequer Y; Tempesta C; Lorscheidt S; Kettel B; Tamaddon L; Jannin V; Demarne F; Lamprecht A; Béduneau A
Int J Pharm; 2015 Mar; 481(1-2):27-36. PubMed ID: 25601199
[TBL] [Abstract][Full Text] [Related]
7. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.
Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ
Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258
[TBL] [Abstract][Full Text] [Related]
8. Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification.
Ozawa M; Tsume Y; Zur M; Dahan A; Amidon GL
Mol Pharm; 2015 Jan; 12(1):204-11. PubMed ID: 25423288
[TBL] [Abstract][Full Text] [Related]
9. Simulated intestinal fluid as transport medium in the Caco-2 cell culture model.
Ingels F; Deferme S; Destexhe E; Oth M; Van den Mooter G; Augustijns P
Int J Pharm; 2002 Jan; 232(1-2):183-92. PubMed ID: 11790502
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of fasted state human intestinal fluid as apical solvent system in the Caco-2 absorption model and comparison with FaSSIF.
Wuyts B; Riethorst D; Brouwers J; Tack J; Annaert P; Augustijns P
Eur J Pharm Sci; 2015 Jan; 67():126-135. PubMed ID: 25433246
[TBL] [Abstract][Full Text] [Related]
11. Do Macrocyclic Peptide Drugs Interact with Bile Salts under Simulated Gastrointestinal Conditions?
Dening TJ; Douglas JT; Hageman MJ
Mol Pharm; 2021 Aug; 18(8):3086-3098. PubMed ID: 34255531
[TBL] [Abstract][Full Text] [Related]
12. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
Ingels F; Beck B; Oth M; Augustijns P
Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
[TBL] [Abstract][Full Text] [Related]
13. Transport of pregabalin in rat intestine and Caco-2 monolayers.
Jezyk N; Li C; Stewart BH; Wu X; Bockbrader HN; Fleisher D
Pharm Res; 1999 Apr; 16(4):519-26. PubMed ID: 10227706
[TBL] [Abstract][Full Text] [Related]
14. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
[TBL] [Abstract][Full Text] [Related]
15. Bile Salt Micelles and Phospholipid Vesicles Present in Simulated and Human Intestinal Fluids: Structural Analysis by Flow Field-Flow Fractionation/Multiangle Laser Light Scattering.
Elvang PA; Hinna AH; Brouwers J; Hens B; Augustijns P; Brandl M
J Pharm Sci; 2016 Sep; 105(9):2832-2839. PubMed ID: 27103012
[TBL] [Abstract][Full Text] [Related]
16. Optimization of the Ussing chamber setup with excised rat intestinal segments for dissolution/permeation experiments of poorly soluble drugs.
Forner K; Roos C; Dahlgren D; Kesisoglou F; Konerding MA; Mazur J; Lennernäs H; Langguth P
Drug Dev Ind Pharm; 2017 Feb; 43(2):338-346. PubMed ID: 27762631
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.
Birch D; Diedrichsen RG; Christophersen PC; Mu H; Nielsen HM
Eur J Pharm Sci; 2018 Jun; 118():144-153. PubMed ID: 29524592
[TBL] [Abstract][Full Text] [Related]
18. Impact of FaSSIF on the solubility and dissolution-/permeation rate of a poorly water-soluble compound.
Frank KJ; Westedt U; Rosenblatt KM; Hölig P; Rosenberg J; Mägerlein M; Brandl M; Fricker G
Eur J Pharm Sci; 2012 Aug; 47(1):16-20. PubMed ID: 22579958
[TBL] [Abstract][Full Text] [Related]
19. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
20. Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions.
Roos C; Dahlgren D; Sjögren E; Sjöblom M; Hedeland M; Lennernäs H
Eur J Pharm Biopharm; 2019 Sep; 142():387-395. PubMed ID: 31306752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
